Tech Company Inital Public Offerings
CoLucid Pharmaceuticals IPO
CoLucid Pharmaceuticals, operating out of Cambridge, debuted as a public company on 5/6/2015.
Transaction Overview
Company Name
Announced On
5/6/2015
Transaction Type
IPO
Amount
$55,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
P.O. Box 425227
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
CoLucid Pharma is a biotech company focusing on therapies for CNS disorders, Migraine, sleep/wake disorders, chronic pain, Alzheimers, and psychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Mathers
Chief Financial Officer
Matthew Dallas
VP - Bus. Development
Linda Hogan
VP - General Counsel
Daniel Boeglin
VP - R & D
Nadia Rupniak
VP - Regulatory Affairs
Bernice Kuca
Browse more venture capital transactions:
Prev: 5/6/2015: Zenefits venture capital transaction
Next: 5/6/2015: B-Temia venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs